Overactive Bladder (OAB)
6 competing products in clinical development for Overactive Bladder (OAB).
Pipeline by Phase
Pre-clinical2
Phase 31
Approved3
All Products (6)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Mirabegron + Placebo | Astellas Pharma | Approved | Completed | 43 |
| Mirabegron + Tolterodine ER | Astellas Pharma | Approved | Completed | 43 |
| Mirabegron tablet + Solifenacin tablet + Propiverine tablet + Imidafenacin tablet + Tolterodine capsule | Astellas Pharma | Approved | Completed | 43 |
| Mirabegron + Placebo | Astellas Pharma | Phase 3 | Terminated | 32 |
| mirabegron + solifenacin + darifenacin + imidafenacin + tolterodine + oxybutynin + trospium + fesoterodine + propiverine | Astellas Pharma | Pre-clinical | Completed | 26 |
| mirabegron + darifenacin + imidafenacin + tolterodine + oxybutynin + trospium + fesoterodine | Astellas Pharma | Pre-clinical | Completed | 26 |